Ultomiris

NDC 25682-028 · Alexion Pharmaceuticals Inc.

Generic nameravulizumab

Dosage formSOLUTION, CONCENTRATE

RouteINTRAVENOUS

Active ingredient(s)RAVULIZUMAB

Strength1100 mg/11mL

Pharmacologic classComplement Inhibitor [EPC], Complement Inhibitors [MoA]

Marketing categoryBLA

Packages

25682-028-01 — 1 VIAL, GLASS in 1 CARTON (25682-028-01) / 11 mL in 1 VIAL, GLASS

J1303 — Injection, ravulizumab-cwvz, 10 mg Medicare Part B payment limit (ASP + 6%): $226.92

FDA lists these products with the same active ingredient.

25682-022 — ravulizumab, 25682-025 — ravulizumab

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.